Steve A. Soergel - Concepedia

Author

Steve A. Soergel

University of Wisconsin–Madison

Also Known As

S A Soergel, S.A Soergel, Steve A. Soergel

Publications

422

Citations

H-Index

Concepts

All Affiliations

University of Wisconsin–Madison

About

Steve A. Soergel is an author at University of Wisconsin–Madison specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	384
2	Immunology	5	5	368
3	Pathology	2	2	59
4	Allergy	1	1	28
5	Cell Biology	1	1	270

Steve A. Soergel

Publications

415

Citations

H-Index

Page 1

	Year	Citations
The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. James W. Young, Lydia Koulova, Steve A. Soergel, Journal of Clinical Investigation Immune ActivationAdaptive Immune SystemImmunologyImmunologic MechanismAntigen Processing	1992	270
Differential cell analysis and phenotypic subtyping of lymphocytes in bronchoalveolar lavage fluid from clinically normal dogs David M. Vail, Peter A. Mahler, Steve A. Soergel American Journal of Veterinary Research Acute Lung InjuryLaboratory ImmunologyLung InflammationNormal DogsImmunology	1995	38
Induction Of Lymphokine-Activated Killer (LAK) Activity in Canine Lymphocytes with Low Dose Human Recombinant InterIeukin-2 <i>in vitro</i> Stuart C. Helfand, Steve A. Soergel, Jaime F. Modiano, Cancer Biotherapy	1994	31
Clinical and immunological effects of human recombinant interleukin-2 given by repetitive weekly infusion to normal dogs Stuart C. Helfand, Steve A. Soergel, Peter S. MacWilliams, Cancer Immunology Immunotherapy InflammationCytokineVeterinary VaccineRepetitive Weekly InfusionAllergy	1994	28
Potential to Involve Multiple Effector Cells with Human Recombinant Interleukin-2 and Antiganglioside Monoclonal Antibodies in a Canine Malignant Melanoma Immunotherapy Model Stuart C. Helfand, Steve A. Soergel, Robin L. Donner, Journal of Immunotherapy Human TumorsMabs 14.G2aCancer ImmunosurveillanceGliomaHuman Recombinant Interleukin-2	1994	21
Methimazole as a protectant against cisplatin-induced nephrotoxicity using the dog as a model David M. Vail, Adnan A. Elfarra, A. James Cooley, Cancer Chemotherapy and Pharmacology Cisplatin-induced NephrotoxicityMedicineClinical PharmacologyPharmacotherapyAnti-cancer Agent	1993	16
The Immunotherapeutic Potential of Activated Canine Alveolar Macrophages and Antitumor Monoclonal Antibodies in Metastatic Canine Melanoma Steve A. Soergel, E. Gregory MacEwen, David M. Vail, Journal of Immunotherapy ImmunologyImmunotherapeuticsImmunotherapyInflammationCanine Melanoma	1999	11

Page 1